These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32667287)

  • 21. Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis.
    Wang PF; Sun ZR; Yu JC; Geng N; Liu LY; Zhu LN; Li J; Yuan HC; Zhao GC; Li ZG
    BMC Neurol; 2021 Nov; 21(1):440. PubMed ID: 34753435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Argatroban Combined With Dual Antiplatelet Therapy on Early Neurological Deterioration in Acute Minor Posterior Circulation Ischemic Stroke.
    Zhou LS; Li XQ; Zhou ZH; Chen HS
    Clin Appl Thromb Hemost; 2020; 26():1076029620904131. PubMed ID: 32013541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
    Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
    Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
    J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Feasibility of Using Argatroban Immediately After Mechanical Thrombectomy for Large Artery Occlusion.
    Kim J; Yi HJ; Lee DH; Sung JH
    World Neurosurg; 2019 Dec; 132():e341-e349. PubMed ID: 31476456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
    Li G; Fan RM; Chen JL; Wang CM; Zeng YC; Han C; Jiao S; Xia XP; Chen W; Yao ST
    Clin Exp Immunol; 2014 Feb; 175(2):285-95. PubMed ID: 24117111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration.
    Xu S; Zhang W; Zhang Y; Xu Z; Wu T
    Discov Med; 2023 Apr; 35(175):185-192. PubMed ID: 37105928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argatroban in thrombotic stroke.
    LaMonte MP
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():39-45. PubMed ID: 12811011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats.
    Kamiya T; Nito C; Ueda M; Kato K; Amemiya S; Terashi A; Katayama Y
    Acta Neurochir Suppl; 2003; 86():195-8. PubMed ID: 14753434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.
    Urabe T; Tanaka R; Noda K; Mizuno Y
    J Thromb Thrombolysis; 2002 Jun; 13(3):155-60. PubMed ID: 12355032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.
    LaMonte MP; Stallmeyer MJ
    J Thromb Thrombolysis; 2004 Apr; 17(2):151-6. PubMed ID: 15306752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
    Kawai H; Yuki S; Sugimoto J; Tamao Y
    J Pharmacol Exp Ther; 1996 Aug; 278(2):780-5. PubMed ID: 8768731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke.
    Hosomi N; Naya T; Kohno M; Kobayashi S; Koziol JA;
    J Neurol; 2007 May; 254(5):605-12. PubMed ID: 17417744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications.
    Chen JL
    Heart Dis; 2001; 3(3):189-98. PubMed ID: 11975790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
    Jang IK; Gold HK; Leinbach RC; Fallon JT; Collen D
    Circ Res; 1990 Dec; 67(6):1552-61. PubMed ID: 2123135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of argatroban for preventing vascular thrombosis in the early period after pediatric living-related donor liver transplantation.
    Na L; Jindong H
    Pediatr Transplant; 2020 Mar; 24(2):e13654. PubMed ID: 31944491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis.
    Valji K; Arun K; Bookstein JJ
    J Vasc Interv Radiol; 1995; 6(1):91-5. PubMed ID: 7703589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.
    Dee B; Lombardi Thomas L; Gulbis A
    Am J Health Syst Pharm; 2014 May; 71(9):711-6. PubMed ID: 24733133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
    Matsuo T; Koide M; Kario K
    Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Bath PM
    Stroke; 2012 Mar; 43(3):623-4. PubMed ID: 22223236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.